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ORIGINAL ARTICLE
Timely and appropriate ambulatory care can pre-
vent complications or exacerbations of diseases
and reduce preventable hospitalization.1–3 In 2003,
the severe acute respiratory syndrome (SARS)
outbreak resulted in 8096 probable cases and
774 deaths in 26 countries.4 The impact of the
SARS epidemic, however, was not limited to peo-
ple who were infected.5 SARS reduced consider-
ably access to medical care and health service
utilization during the outbreak.5–13 The effects of
this reduced utilization on the population’s health
has been studied rarely.
Taiwan was confirmed to have 346 probable
cases and 37 deaths caused by SARS, and was one
of the countries affected significantly by the out-
break.4 Due to the fear of SARS, many patients
and care providers were reluctant to seek or provide
care. As a result, the level of health services uti-
lization for outpatients,5,6 inpatients,5,6 hospices,7
and emergency care,8–10 decreased significantly
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during the SARS outbreak in Taiwan. Among the
different types of health care, inpatient care had
the greatest reduction (35.2%) in utilization, fol-
lowed by ambulatory care (16.7%). Similar
trends were also observed in the greater Toronto
area11,12 and Hong Kong.13,14 Within ambulatory
care, the reduction in utilization was greatest for
minor acute diseases and modest for chronic
conditions.6,15 Health service utilization for life-
threatening diseases was nearly unaffected.10,15
Although a SARS outbreak has not recurred,
other potential infectious diseases such as pan-
demic influenza or avian flu may emerge in the
future. To guide preparation and planning, it is
necessary to investigate the potential health im-
pact of decreased service utilization caused by
disruption to the health care system during major
outbreaks. Ambulatory-care-sensitive conditions
(ACSCs) are those for which timely and adequate
outpatient care can prevent future hospitalization.3
These conditions have been used widely to meas-
ure access to and performance of primary care,
and can be used to identify areas for improving
access and quality in health care delivery.1–3,16,17
Therefore, in this study, we used these conditions
as indicators to examine whether the decreased
access to primary health care caused by SARS,
which has been reported in previous studies,5,6,15
had an impact on population health, as meas-
ured by hospitalization for chronic ACSCs.
The specific aim of this study was to explore
the effect of the SARS outbreak on hospitaliza-
tion for chronic ACSCs after the SARS outbreak.
The following reasons provided explanations on
why we excluded acute hospitalization for ACSCs:
1. Health services utilizations of acute conditions
were not significantly affected by SARS during
the outbreak.10,11 2. Acute conditions, in general,
are more life-threatening. Hospitalization related
to inappropriate primary care might have occurred
immediately following the event, and not a few
months later. 3. Patients with chronic conditions,
particularly the less severe ones, are more likely
to delay ambulatory care during the SARS out-
break.6,15 Therefore, we only included chronic
conditions in this study. The study finding might
be of interest particularly to health policy makers
and those in health services that are responsible
for the preparation and planning for a major
outbreak of infectious disease.
Methods
Study design
This was an exploratory study. We applied a 
population-based interrupted time series design
to compare the actual with predicted hospitaliza-
tion for ACSCs after the SARS outbreak, to iden-
tify conditions with increased hospitalization that
might have been caused by untimely or inappro-
priate primary care during the SARS outbreak.
The National Health Insurance (NHI) claims data
during 1997–2002 were used to estimate the trends
in hospitalization for ACSCs before the SARS out-
break, and to generate the predicted value in 2003.
The interrupted time series design allowed us to
take into account any underlying trends or sea-
sonal influences prior to the SARS outbreak, and
then quantify accurately the subsequent impact of
SARS. Any changes in the trends that occurred after
the outbreak were assumed to have been caused
by the outbreak. Monthly admission rates for
each ACSC were calculated throughout the study
period based on the claims data from January
1997 to December 2003. To provide a reference,
we included a non-ACSC condition, appendicitis,
in this study as a comparison. Besides, because
of our inability to obtain databases that link
individual inpatient and outpatient data, we pro-
vided the aggregate statistics of outpatient uti-
lization of ACSCs for reference.
Data source
The data source for this study was the “Inpatient
expenditures by admissions (DD)” and “System-
atic sampling data of outpatient (SCD)” datasets
provided by the Bureau of the NHI, Department of
Health, and managed by National Health Research
Institutes. The DD dataset included each inpa-
tient claim of every NHI beneficiary in Taiwan from
1997 to 2003; whereas, the SCD dataset included
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0.2% systematic samples of all outpatient claims
during the same period. NHI is a universal health
insurance program, which covers about 99% of
the population. Therefore, almost all hospital
admissions are recorded in the NHI claims data-
base. We used encrypted beneficiaries’ identifica-
tion (ID) number and encrypted hospitals’ ID
number to link the data and to ensure that each
claim only appeared once in the analyses.
SARS periods
Since the first SARS case was identified on March
14, 2003 in Taiwan, the epidemic increased at
the end of April, and reached its peak in May and
June of 2003.18 Taiwan was removed finally from
the list of SARS-affected countries by the World
Health Organization (WHO) on July 5, 2003.
Therefore, we defined April–June 2003 as the
SARS outbreak period and January–March 2003
as the pre-SARS period. We then defined two post-
SARS periods: the first 3 months after the out-
break (July–September) was post-SARS-1 period,
and the following 3 months (October–December)
was the post-SARS-2 period.
Hospitalization for ACSCs measurement
Hospitalization for ACSCs has been used widely
as a marker of access and quality of care.1–3,16,17
The Agency for Healthcare Research and Quality
(AHRQ) has defined a list of 16 ACSCs.3 Ten of
these are chronic conditions, including uncon-
trolled diabetes without complications, diabetes
short-term complications, diabetes long-term
complications, diabetes-related lower-extremity
amputation, pediatric asthma, adult asthma, hy-
pertension, chronic obstructive pulmonary dis-
ease (COPD), angina without procedure, and
congestive heart failure. One is birth outcome
(low birth weight) and five are acute conditions
(bacterial pneumonia, dehydration, urinary tract
infection, perforated appendix, and pediatric
gastroenteritis).
We only included chronic conditions as indi-
cators in this study because they were more likely
to be affected by SARS than acute conditions.
However, among the 10 chronic conditions, we
also excluded long-term diabetes complications
and lower-extremity amputation among diabetic
patients because the incidence of these condi-
tions is low, and a longer study period would
have been required to observe these outcomes.
Furthermore, the AHRQ guidelines for ACSCs
states that the indicator for uncontrolled dia-
betes is designed to be combined with diabetes
short-term complications.3 Accordingly, for dia-
betes, we only included a combined diabetes
measure that comprised uncontrolled diabetes
without complications and diabetes short-term
complications. As a result, we included seven
ACSCs in this study. All the indicators were iden-
tified by the principal diagnoses listed on the
AHRQ PQIs version 2.1, revision 4 and coded by
the International Classification on Diseases, ninth
revision, Clinical Modification (ICD-9-CM).
Statistical analyses
First, we used the monthly hospitalization rates
for each condition between January 1997 and
December 2002 to fit the time series auto-regressive
integrated moving-average (ARIMA) model.19
ARIMA models are fitted to time series data to
better understand the underlying trends in the
data and to predict data points in the future. The
Ljung-Box Q-statistic was used to check whether
lack-of-fit existed in these models.20 Predicted
monthly hospitalization rates for each selected
condition in 2003 were obtained subsequently
from the ARIMA models. We then compared the
actual monthly hospitalization rates and the 
predicted rates with the 95% CI. We considered
the differences between the actual and predicted
monthly rate as significant if the actual hospital-
ization rate of a given condition was beyond the
95% CI of the predicted rate. All analyses were
performed using SPSS version 11.5 (SPSS Inc.,
Chicago, IL, USA) for Windows.
Results
A total of 120,330 hospitalizations were observed
for the seven selected ACSCs during four time
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periods (pre-SARS, SARS, post-SARS-1 and post-
SARS-2) in 2003. Table 1 displays the actual num-
ber of hospitalizations for each selected ACSC
and appendicitis, as well as the percentage changes
in the number of hospitalizations from 2002 to
2003. Among the seven ACSCs, COPD had the
most hospital admissions, with approximately
42,000 patients. All the hospitalizations for se-
lected ACSCs were reduced in the SARS period
compared with those in 2002, most notably
among circulatory and respiratory conditions. The
hospitalizations for most conditions were still
reduced in the post-SARS-1 period, with the ex-
ception of diabetes and hypertension, which in-
creased more than 10%, when compared with
the numbers in 2002, during the post-SARS-2 
period. For appendicitis, the admission numbers
had stable reductions in pre- and post-SARS peri-
ods. As well as ACSCs, the number of appendicitis
admissions decreased substantially in the SARS
period. Table 1 also presents the number of out-
patient visits for each selected ACSC, and the
patterns for outpatient visits were similar to
those for ACSC admissions in the SARS period.
However, for diabetes, the reduction in outpa-
tient visits was much more than the reduction in
the admissions.
Table 2 presents the predicted hospitalization
rates, the associated 95% CI obtained from the
ARIMA model, and the differences between the
actual and predicted hospitalization rates among
the four periods. During the pre-SARS period,
admission rates for all conditions did not differ
significantly from their predictive values. How-
ever, during the SARS period, admission rates for
pediatric asthma, COPD, and angina without pro-
cedure were reduced by 5.28, 7.47, and 2.50 per
100,000 population per month, and were signifi-
cantly (p<0.05) different from their respective pre-
dictive values. In general, the actual hospitalization
Table 1. Number of hospitalization and outpatient visits among selected chronic ambulatory-care-sensitive conditions (ACSCs)
and non-ACSCs
Conditions
pre-SARS SARS Post-SARS-1 Post-SARS-2 
[Jan–Mar] [Apr–Jun] [Jul–Sep] [Oct–Dec]
Number Change* Number Change* Number Change* Number Change*
ACSC admission
Adult asthma 7452 5.48% 3939 −36.59% 3465 −39.73% 4561 −19.88%
Pediatric asthma 1815 1.11% 822 −55.57% 869 −47.33% 1831 −14.68%
COPD 15,180 6.47% 8759 −28.94% 8115 −28.33% 10,288 −6.61%
CHF 7462 1.65% 4816 −18.48% 5303 −1.27% 6171 0.19%
Hypertension 2708 −10.00% 1814 −36.93% 2373 −15.37% 3009 10.54%
Angina without procedure 3161 −3.10% 2344 −36.20% 3230 −11.09% 3252 −7.17%
Diabetes 1955 −0.76% 1575 −4.02% 1860 11.64% 2201 26.28%
Non-ACSC admission
Appendicitis 5589 −6.32% 5697 −16.07% 6173 −5.41% 5535 −6.14%
Outpatient visit†
Adult asthma 277.0 3.55% 206.5 −13.78% 210.0 −3.67% 259.0 4.65%
Pediatric asthma 173.5 16.84% 106.5 −14.80% 100.5 −23.86% 180.0 9.09%
COPD 457.5 −4.19% 363.5 −12.41% 320.0 −11.23% 381.5 −4.63%
CHF 74.5 −3.87% 67.0 −16.77% 67.0 −10.67% 77.0 9.22%
Hypertension 2269.5 5.98% 1953.0 −11.41% 2072.0 −5.11% 2386.5 7.02%
Angina without procedure 382.0 −5.68% 351.5 −11.46% 392.0 −7.33% 461.5 8.72%
Diabetes 1408.5 9.70% 1245.0 −12.48% 1362.5 −7.75% 1416.5 3.62%
*Compared with the numbers during the same 3-month period in 2002; †unit: 1000 outpatient visits. COPD = chronic obstructive pulmonary disease; 
CHF = congestive heart failure.
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rates for respiratory and circulatory conditions
were lower than the predicted rates in the post-
SARS periods. The admission rates for all respira-
tory conditions were lower compared with their
predictive values in the post-SARS periods; how-
ever, the differences were significant only in the
post-SARS-1 period. Yet they were higher than the
predicted rates for hypertension (during post-
SARS-2) and diabetic conditions. The diabetes
admission rates increased by 0.52 per 100,000
population per month, which was significant
(p < 0.05) in the post-SARS-2 period. Compared
with the ACSCs, the admission rate for appendici-
tis remained insignificant during all study periods.
Figures 1–3 display the monthly trends in
hospitalization rates for the seven selected ACSCs,
with predicted values and 95% CI indicated for
2002 and 2003. During the SARS period, the ac-
tual hospitalization rates for all selected ACSCs
were significantly lower than the lower boundary
of the 95% CI of the predicted rates for at least 
1 month, except for diabetes. The differences in
hospitalization rates for respiratory conditions
during the post-SARS-1 period, shown in Figure
1, were also significant for at least 1 month. Yet,
only the differences in pediatric asthma re-
mained significant in two of the three months
during the post-SARS-2 period.
In Figure 2, the actual hospitalization rates
for the three circulatory conditions all fell within
the range of the 95% CI of their predicted values
in both post-SARS periods. Figure 3 shows that
the actual admission rates for diabetes also fell
within the 95% CI during both post-SARS peri-
ods. Nonetheless, the actual admission rates for
diabetes were significantly higher than the pre-
dicted rates and exceeded the upper limit of the
95% CI at the end of 2003.
Discussion
We found that the actual hospitalization rates 
for six selected ACSCs, particularly respiratory
conditions, were significantly lower than their
predicted rates for at least 1 month during the
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Figure 1. Hospitalization rates for respiratory conditions, January 2002 to December 2003.
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SARS period. This trend remained significant
only in respiratory conditions during the post-
SARS-1 period. The admission rates for two con-
ditions, hypertension and diabetes, were higher
than the predicted rates during either of the post-
SARS periods, but the differences were signifi-
cant only for diabetes in the post-SARS-2 period.
In contrast, no significant change in admission
rates for the reference condition appendicitis 
was observed during the entire study period.
The reduction in hospitalization rate was most
profound among respiratory conditions and was
consistent with previous findings during the SARS
period.6 These trends continued to be significant
in the post-SARS-1 period. Since SARS is associ-
ated with the respiratory system, people with res-
piratory conditions were more likely to avoid
hospital contact compared with people with other
conditions.6 The Health Belief Model21 can be
used to explain such behavior, when people may
have evaluated the perceived susceptibility and
benefit before taking a health-related action. In
addition, people were more cautious about their
health during the SARS outbreak and took all
means available to prevent respiratory infection
(e.g. wearing masks and avoiding public gather-
ings).22 Another explanation is that the WHO
warning about the return of SARS may have pro-
vided a booster effect during the post-SARS-1 
period and even in the post-SARS-2 period.23
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Figure 2. Hospitalization rates for circulatory conditions, January 2002 to December 2003.
Our study indicated that the actual admission
rates for diabetes were significantly higher than
the predicted values during the post-SARS-2 
period. Diabetic patients might have worse access
to care because several hospitals discontinued
their emergency and routine services, or mailed
the medications to patients during the SARS out-
break.24,25 Since medication alone is not sufficient
for diabetes, it is possible that some difference
between actual and predicted admission rates for
diabetes during the post-SARS-2 period resulted
from under-use of regular or effective care during
the SARS outbreak. We found that outpatient uti-
lization reduced by 12.48% in SARS period. If we
take the increased trend for diabetes in the pre-
SARS period into consideration, the actual reduc-
tion was as high as 19.42%, and was ranked the
second among all the ACSCs in our study. This
might support partially our above explanation
and explains why the admission rates for other
ACSCs were not elevated significantly after the
SARS outbreak. However, we were unable to ex-
amine the relationship between outpatient and
inpatient utilization directly, to provide further
evidence, because the NHI outpatient database
provided by NHRI is sampled based on outpa-
tient visits rather than individuals; thus, we were
unable to obtain meaningful individual samples
in the present study.
Previous studies have shown that hospitaliza-
tion rates declined during the SARS period in
Taiwan,5,6 and have found no significant changes
in mortality, readmission, and complication rates
for critically ill patients in Toronto.26,27 However,
the present study is possibly the first to explore
the possible impact of SARS on hospital admis-
sions in the post-SARS period in Taiwan, by fo-
cusing on specific conditions such as ACSCs. In
addition, the application of the population-based
interrupted time series design, using a non-ACSC
condition for comparison, did allow us to take
into account the underlying trends and seasonal
effect of the admission rates, and rule out other
possible contemporary influences present during
the study period. Besides, the Ljung-Box Q-statistic
enabled us to select the best-fitting ARIMA models,
which was indicated by the fact that most of the
actual values in the pre-SARS periods were within
the 95% CI of the predicted values.
This study however has some limitations that
warrant discussion. First, we did not compare the
changes in ACSC admissions among areas with
different impacts of SARS. This was because almost
every area in Taiwan was in a state of alert during
the SARS outbreak, and many hospitals suspended
emergency, outpatient, inpatient or all services
during that time, even hospitals in areas without
any probable SARS cases, such as greater Chiayi
area, Taitung and Yilan Counties. Second, we
were unable to evaluate the impact of SARS after
2003 because NHI introduced many interventions
in 2004, including: reduction of outpatient and
increase of inpatient budgets; implementation 
of hospital self-management/Hospital Center of
Excellence Initiative; revision on NHI fee sched-
ules; and the launch of family physicians initia-
tives. It would be inappropriate to relate the
changes between the post-SARS period and 2004
to the impact of SARS. Besides, the accuracy 
of the predictions from the time-series model
would be greatly reduced for a longer period.
Third, we did not conduct a simple correlation
analysis between aggregate outpatient and inpa-
tient statistics, because the health seeking behav-
ior might have varied among conditions with
different severity and likelihood of acquiring SARS
at health facilities (e.g. patients with respiratory
diseases were more likely than others to acquire
SARS).
In conclusion, we found that the impact of
SARS on hospital admission rates after the SARS
outbreak varied among different conditions. It had
a negative and significant impact on respiratory
conditions in the first post-SARS period, no sig-
nificant impact on circulatory conditions, and a
positive impact on diabetes conditions during the
second post-SARS period. In addition, the admis-
sion rates for most ACSCs, except for diabetes,
did not change in the post-SARS period. The re-
ductions in outpatient utilization during the SARS
outbreak did not appear to affect adversely admis-
sions for most ACSCs.
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